Arcadia Biosciences

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Davis, CA.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Arcadia Biosciences reports positive Q1 results, eyes revenue growth

Arcadia Biosciences delivered strong financial performance in Q1 2024, driven by revenue growth and cost management. The company faces challenges in retail execution but has opportunities for revenue growth through brand expansions and strategic partnerships.

Arcadia Biosciences reports strong Q2 driven by Zola growth

Arcadia Biosciences delivered solid financial performance in Q2 2024 driven by Zola Coconut Water.
Efficient cost-saving measures and strategic asset monetization bolstered profitability.
Challenges include managing increased costs and sustaining growth momentum.
Opportunities lie in expanding Zola brand, diversifying revenue streams, and strategic partnerships.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. It uses screening, breeding, and biotechnology techniques to create agricultural products for consumers, processors, and farmers. Its products include GoodWheat pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care. The company was founded by Eric J. Rey and John G. Sperling in 2002 and is headquartered in Dallas, TX.

RKDA has had a number of important developments which I review here. They include: A transformative transaction in the HB4 soybean space.

The Future Looks Bright For Arcadia Biosciences

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q3 2020 Results - Earnings Call Transcript

Bioceres Crop Solutions Corp

DAVIS, Calif., Nov. 12, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc. (Nasdaq: RKDA) today announced a series of strategic transactions with Bioceres Crop Solutions Corp (NYSE: BIOX), including the sale of its membership interest in Verdeca, a soybean joint venture the two companies...

Arcadia Biosciences (RKDA) Announces a Series of Strategic Transactions with Bioceres Crop Solutions (BIOX)

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q2 2020 Results - Earnings Call Transcript

DAVIS, Calif., Aug. 13, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.

Arcadia Biosciences Announces Second-Quarter and First-Half 2020 Financial Results and Business Highlights

DAVIS, Calif., July 30, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.

Arcadia Biosciences Announces Date of Second Quarter and First Half 2020 Financial Results and Business Highlights Conference Call

Chinese Approval Of HB4 Soybeans Could Be A Major Catalyst For Arcadia Biosciences

DAVIS, Calif., July 6, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that it has entered into a definitive agreement with an institutional...

Arcadia Biosciences Announces Warrant Exercise Transaction to Generate $2.5 Million in Gross Proceeds

Arcadia Biosciences: An Update On Its Hemp/CBD Operations

DAVIS, Calif., May 18, 2020 /PRNewswire/ -- Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the closing of a transaction resulting in gross cash proceeds to the...

Arcadia Biosciences Announces Cash Proceeds of $6.8 Million from Warrant Exercise

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q1 2020 Results - Earnings Call Transcript

Arcadia Biosciences, Inc. (RKDA) CEO Matthew Plavan on Q4 2019 Results - Earnings Call Transcript

Arcadia Biosciences Inc (NASDAQ: RKDA), a developer of food ingredients and nutritional oils, with some pre-existing hemp assets and a partnership with Shane Victorino, a former MLB player and son of the mayor of Maui Mike Victorino, announced on Tuesday it's launching a new product line under the GoodHemp name.

Arcadia Bio Launches Hemp Seeds Brand: 'Just The Beginning Of Our Ambitions'

I'm Joining Insiders In Buying Arcadia Biosciences Stock

Arcadia Biosciences, Inc. (RKDA) CEO Matt Plavan on Q3 2019 Results - Earnings Call Transcript

Arcadia Biosciences, Inc. (NASDAQ: RKDA) reported third-quarter revenue of $392,000 on Wednesday, an increase from revenue of $370,000 in the same quarter in 2018.

Arcadia Biosciences Falls On Quarterly Net Loss of $14.2M, CEO Says Hemp Research 'More Valuable Than Ever'

Preview Of Q3 For Arcadia Biosciences

Arcadia Biosciences, Inc. (NASDAQ: RKDA) released Tuesday an update on its joint venture with Legacy Ventures Hawaii, Archipelago™ Ventures.

Arcadia Biosciences Updates Joint Venture With Archipelago Ventures

USDA approval of soybean could be a major catalyst longer term for RKDA, potentially generating up to $125M in annual revenues at 60%+ margins.

Arcadia Biosciences: Trading At Cash With Several Near-Term Catalysts

Arcadia Specialty Genomics, a hemp-focused operating unit of crop innovation company Arcadia Biosciences Inc (NASDAQ: RKDA), announced this week plans for a new sun-grown hemp cultivation and agronomic research facility in Imperial County, California.

A Subsidiary Of Arcadia Bio Received A New Hemp License In California

Shares of agricultural biotech company Arcadia Biosciences Inc. shot up 35% on Monday after the company said it expects total revenues in 2020 and 2021 to exceed $10 million and $30 million, respectively.

Arcadia stock rockets 35% after company issues bullish guidance for 2020 and 2021

Agricultural biotechnology company Arcadia Biosciences, Inc. (NASDAQ: RKDA) announced Monday that it has signed a binding term sheet agreement with Arista Cereal Technologies and Bay State Milling Company for the commercialization of its high-fiber wheat.

Arcadia Biosciences Rallies After Announcing Financial Guidance, Partnerships To Market High-Fiber Wheat

Arcadia Biosciences, Inc. (RKDA) CEO Rajendra Ketkar on Q2 2019 Results - Earnings Call Transcript

Arcadia Biosciences (NASDAQ: RKDA) is expected to announce Tuesday a joint venture with Legacy Ventures Hawaii to grow, extract and sell superior hemp products, Benzinga has learned exclusively.

Scoop: Arcadia Biosciences Announces Joint Venture For Hemp Project In Hawaii

Arcadia Biosciences (RKDA) delivered earnings and revenue surprises of -103.28% and -60.50%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?

News for Arcadia Biosciences Stock (RKDA)